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It is now well established that primary cultures of
embryonic muscle tissue (1, 2) and muscle cell
lines (2, 3) elaborate acetylcholine receptor dur-
ing the process of muscle formation . However, the
precise timing of the appearance of receptor with
regard to the cessation of DNA synthesis, cell fu-
sion, and the synthesis of the cytoplasmic and
contractile proteins, major events that mark the
course of muscle differentiation, has yet to be
elucidated. Previous studies (1-3) have been
hampered by the lack of rapid fusion kinetics .
We have measured the appearance of acetylcholine
receptor in rapidly differentiating cultures of em-
bryonic chick skeletal muscle, under normal and
fusion-arrested conditions (4-6), using iodine- 125-
labeled neurotoxins from elapid snake venoms as
specific markers (8). This method has been used
to assay receptor in adult muscle (9-11), electro-
genic tissue (12), and cultures of embryonic muscle
(1-3) . This paper demonstrates that the elabora-
tion of receptor in differentiating muscle, unlike
other muscle proteins which have been previously
assayed during differentiation (4-7), is not de-
pendent upon the fusion process and can proceed
in the absence of fiber formation.
METHODS
Cultures
Primary cultures of 12-day embryonic chick breast
muscle were prepared as described earlier and were
plated on 50-mm plastic Petri dishes (Nunc) coated
with collagen (5, 14). Cells were plated at initial den-
sities of 0.5-2.5 X 106 cells per dish. Growth condi-
tions and fusion kinetics were the same as previously
reported (5, 13, 14) . Over this range of initial plating
densities the rate of cell fusion is constant and the
onset of cell fusion commences from 32 to 38 h in
vitro (14) .
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241Preparation of Toxins
Neurotoxins were purified from the venoms of
Naja naja siamensis (a-neurotoxin) (15) and Bungarus
multicinctus (a-bungarotoxin) (19). 100-µg portions
of the purified toxins were iodinated with 2.50 mCi of
carrier-free iodine-125 by the chloramine-T method
(16) and separated from unincorporated iodine by gel
filtration through a 0.9 X 25 cm column of Sephadex
G-25 (fine) in column buffer containing 0 .05 M po-
tassium phosphate buffer pH 7 .5 and 2 mg/ml bovine
serum albumin (BSA). Aliquots of 0.50 ml of the
pooled peak fractions containing approximately 5
,ug of toxin were frozen at -20 °C in column buffer.
Under these conditions approximately 50-70% of the
labeled iodine in the reaction mixture was incorpo-
rated into the toxin as judged by the radioactivity
traveling with the toxin peak . The toxins used in these
experiments had initial specific activities of approxi-
mately 40-50 Ci/mmol for a-neurotoxin and 100-
120 Ci/mmol for a-bungarotoxin. Higher specific
activities could be obtained with the a-bungarotoxin
as it has an additional histidine and tyrosine residue
(8). These are believed to be the reactive groups in
the iodination procedure used here (2, 16) .
Toxin-Binding Assay
The binding assay was performed in the tissue cul-
ture dishes (2) . Dishes were rinsed three times with
2.5-3.0 ml of saline (0.9% sodium chloride wt/vol)
at room temperature and then covered with 0 .9 ml
of Eagle's minimal essential medium (MEM) minus
calcium, containing 2 mg/ml of BSA . Cultures were
equilibrated for 20 min at 37°C with or without in-
hibitors. Iodine-125 toxin was then added to a final
concentration 1 X 10-8 M and the dishes were kept
at 37°C. Although specific toxin binding reached
saturation levels within 20 min, incubations were
routinely carried out for I h . Specific toxin binding
did not increase for either toxin with a tenfold in-
crease in toxin concentration (10-7 M), suggesting
little toxin inactivation by excess iodination (2). The
incubation medium was removed by aspiration, the
cultures were rinsed three times with 3 .0 ml of room
temperature saline and the cells were removed from
the culture dish with the application of 1 .5 ml of
trypsin solution (0.3% in saline) followed by two
additional 1 ml trypsin rinses . These were pooled and
counted in a Packard gamma counter (Packard
Instrument Co., Inc., Downers Grove, Ill.). The
efficiency of counting was not determined. Nonspe-
cific background binding was determined from the
extent of labeling in the presence of 10-b M dec-
amethonium or 10-4 M d-tubocurarine and toxin
bound to empty collagen-coated culture dishes . Data
are reported as specific counts bound per culture and
were calculated as the difference between total and
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nonspecific counts bound. Counts were not nor-
malized to the slight variation in the number of cells
per culture as this was less than 10% .
Fusion Arrest
Calcium-free horse serum and embryo extract were
prepared with Chelex-100. Serum and embryo ex-
tract were mixed 5:1 and made into a 10% slurry
with washed, sterile Chelex-100 (Bio-Rad Lab-
oratories, Richmond, Calif.). This mixture was
stirred slowly overnight in the cold at 4 °C. The resin
was removed from solution by a 10 min centrifuga-
tion at 2,000 rpm in a tabletop Sorvall GLC-l (Ivan
Sorvall, Inc., Newtown, Conn.), decanted under
sterile conditions into 6-ml aliquots, and stored
frozen at -80 °C. To prepare sterile Chelex-100, the
resin was allowed to stand overnight in 95% ethanol.
The ethanol was decanted and the resin was equili-
brated with sterile, calcium-free MEM, containing no
phenol red, by three centrifugation cycles with 5 vol
of medium at 1,200 rpm in the tabletop centrifuge .
Cultures to be fusion blocked were plated in normal
culture medium for the first 24 h, were rinsed three
times with 3 ml of saline at 37 °C, and covered with
2.50 ml of low calcium medium containing 25 lsM cal-
cium. Low calcium medium was prepared by mixing
12 ml of the calcium-free embryo extract mixture,
88 ml of calcium-free MEM, and the appropriate
amount of CaC12 from a 100 mM stock solution per
100 ml of medium. Under these conditions fusion
arrest and fusion kinetics, upon the addition of cal-
cium to the medium, were identical to those described
earlier (5) for EGTA fusion-blocked cultures.
Cell Counts and Fusion Index
Cell counts to determine rates of fusion and cell
densities were carried out as described previously (5,
13, 14). Saline-rinsed cultures were fixed with 100%
methanol, stained with a 10% o aqueous solution of
Giemsa's stain for 30 min, rinsed once with water to
remove excess stain, and air dried before addition of
cover slips. Giemsa staining was found to be superior
to hematoxylin as cytoplasmic background was much
lower, obviating RNase treatment.
RESULTS
Specificity of Toxin Binding
As shown in Table I, the presence of either
10-4 M d-tubocurarine or 10 M decamethonium
resulted in a significant decrease in the binding of
the labeled neurotoxins in the cultures . These
compounds are known specific ligands for the
acetylcholine receptor and bind to the same sub-
site as the neurotoxins (17, 18) . The binding elim-TABLE I
Iodine-125 Toxin Counts per Minute Bound Per Culture in the Presence of.
Values were obtained from different control cultures in separate experiments (A, B)
after toxin binding had reached a maximum (60-75 h) . For incubation conditions see
Methods. Concentrations of decamethonium and d-tubocurarine were 10-'M and 10-4
M, respectively. Specific labeling is the difference between counts per minute bound
with no additions minus counts per minute obtained with decamethonium . Plating
densities : (A) 0.5 X 106 cells per 50-mm dish ; (B) 2 .5 X 10 6 cells per 50-mm dish .
inated with these agents was taken as the specific
component of labeling . Empty culture plates
coated with collagen bound amounts of toxin
equivalent to the nonspecific component of label-
ing established with these inhibitors. Decametho-
nium resulted in a greater inhibition of labeling
than did d-tubocurarine, at a tenfold lower con-
centration, in agreement with Vogel et al. (2),
W
and was routinely used to establish specificity of a
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Appearance of Receptor in Culture
The time-course of appearance of the toxin
binding component in diflerentiating cultures is
shown in Figs. I and 2. Under standard culture
conditions both labeled neurotoxins gave similar
kinetic patterns for the elaboration of acetylcholine
receptor. Although both neurotoxins gave the same
relative increase in labeling during differentiation,
approximately eight- to tenfold, a-bungarotoxin
yielded the greatest net increase in specific counts
due to its higher specific activity. As shown, the
amount of receptor per culture does not begin to
increase substantially until 55-60% of the myo-
blasts have fused to form multinucleated fibers.
Near the end of the main fusion period, around 50
h in culture, toxin binding begins to increase
dramatically. By 65 h, receptor has increased 5-6
times above the 50 h level with little increase in
the percentage of fusion . Under standard culture
conditions, therefore, the appearance of acetyl-
choline receptor in the plasma membrane of dif-
ferentiating embryonic chick muscle follows the
main period of cell fusion.
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FIGURE 1 Kinetics of receptor appearance and cell
fusion in standard cultures asayed with a-neurotoxin .
Plating densities : 0.5 X 106 cells per dish (•-•) ;
1.0 X 106 cells per dish (/-/) ; percent fusion (A-A).
Counts per minute in parentheses refer to plating densi-
ties of 1 X 106 cells per dish. Cells scored for fusion had
an initial plating density of I X 106 cells per dish.
Fusion Arrest and the Elaboration of
Acetylcholine Receptor
In order to determine if receptor elaboration
was dependent upon cell fusion, cultures of fusion-
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Toxin No additions
Decame-
thonium d-Tubocurarine No cells
Specific
labeling
(A) a-Neurotoxin (1) 1,268 104 190 111 1,164
(2) 1,252 120 206 109 1,132
(3) 1,355 132 205 120 1,223
(B) a-Bungarotoxin (1) 10,827 750 1,306 850 10,077
(2) 11,294 765 1,275 790 10,529244
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FIGURE 2 Kinetics of receptor appearance and cell
fusion in control and fusion-arrested cultures assayed
with a-bungarotoxin. Plating density: 2.5 X 106 cells
per dish. Toxin binding in control cultures (N-/) and
in fusion-arrested cultures (0--0) ; fusion in control
(A-A) and fusion-arrested cultures (A-A); toxin
binding in cultures maintained under fusion arrest in low
calcium medium (unreleased) (O). Time at which cal-
cium concentration was restored to control levels in
fusion arrested cultures is indicated by arrow .
arrested myoblasts were prepared by growing the
cells in medium containing 25 µM calcium. Such
cells are arrested in a postmitotic state and do not
divide before cell fusion (5). Under these culture
conditions less than 15% of the myoblasts had
fused during the entire culture period whereas
control cultures had fused to 65 °%o (Fig. 2). Never-
theless, receptor elaboration proceeded at rates
similar to those of control cultures and reached
comparable levels in the absence of overt cell
fusion . Addition of calcium to the fusion-arrested
cultures at 65 b, a procedure which resulted in
rapid cell fusion to control levels in less than 7 h
(5), had no apparent effect on the quantity of
specific toxin binding as compared to cultures
maintained in low calcium medium. Thus, the
elaboration of acetylcholine receptor does not de-
pend upon cell fusion per se, but can take place in
the postmitotic, fusion-arrested cell population .
DISCUSSION
The results reported here show that receptor ap-
pearance follows cell fusion under normal culture
conditions. Under low calcium conditions, how-
ever, acetylcholine receptor is elaborated in the
absence of cell fusion. In contrast, the majority of
cytoplasmic and structural proteins characteristic
of differentiated muscle are apparently dependent
upon the fusion process for their elaboration (4-7).
These findings suggest a scheme in which the
regulatory pathways in the development of chem-
ical sensitivity (membrane differentiation) and
contractility (cytoplasmic differentiation) are not
coupled.
Assuming that acetylcholine sensitivity is a re-
flection of the presence of acetylcholine receptor at
levels detectable by labeling with neurotoxin, our
results with fusion-blocked cells support the con-
clusion of Fambrough and Rash (1), using rat
myoblasts, that differentiating cells can become
sensitive to acetylcholine in the absence of cell
fusion. However, our findings do not support the
notion that acetylcholine sensitivity precedes or is
coincident with myotube formation and the syn-
thesis of the contractile machinery as has been
proposed (1, 3). Acetylcholine receptor does not
increase above prefusion levels until several hours
after fusion in control cultures . There is recent
evidence suggesting that this discrepancy is not
attributable to a species difference in the mode of
differentiation : myoblasts in differentiating cul-
tures of both chick and rat embryonic muscle
have been found to bind little or no labeled neuro-
toxin (2). In addition, it is now established that
the synthesis of proteins associated with contraction
is dependent upon previous fusion in both chick
and rat muscle cultures (4-7). Therefore, the se-
quence of events in myogenesis for both species
appears to be the same. Under standard culture
conditions both the elaboration of acetylcholine
receptor and the synthesis of the contractile
machinery in chick skeletal muscle follow cell
fusion for the majority of cells in culture .
SUMMARY
Differentiating cultures of embryonic chick breast
muscle with rapid fusion kinetics have been used
to determine the relationship between cell fusion,
a primary event in muscle differentiation, and the
appearance of acetylcholine receptor as measured
by the binding of two neurotoxins from elapid
snake venoms. Under normal culture conditionsthe amount of acetylcholine receptor begins to
increase at significant rates only after the main
fusion period has been completed . Postmitotic
myoblasts prevented from fusing by calcium depri-
vation elaborate acetylcholine receptor at com-
parable rates to control levels even though cyto-
plasmic differentiation is repressed under these
conditions. It is suggested that the differentiation
of the excitation and contractile systems in skeletal
muscle can proceed independently of one another .
We wish to thank Dr . I. Silman and Dr. V. Teichberg
of the Department of Biophysics, Weizmann Institute
of Science for kindly supplying a-bungarotoxin and
a-neurotoxin.
B. Paterson is a National Science Foundation Post-
doctoral Fellow andJ . Prives is a Muscular Dystrophy
Associations of America, Inc ., Postdoctoral Fellow.
Received for publication 9 March 1973, and in revised form
30 May 1973.
REFERENCES
1 . FAMBROUGH, D., and J . E. RASH. 1971 . Develop-
ment of acetylcholine sensitivity during myo-
genesis. Dev. Biol. 26 :55.
2. VOGEL, Z., A. J. SYTKOWSKI, and M. W. NIREN-
BERG. 1972. Acetylcholine receptors of muscle
grown in vitro. Proc. Natl. Acad. Sci. U. S. A. 69:
3180.
3. PATRICK, J., S. F. HEINEMANN, J . LINDSTROM, and
D. SCHUBERT. 1972. Appearance of acetyl-
choline receptors during differentiation of a
myogenic cell line . Proc. Natl. Acad. Sci. U. S. A.
69:2762.
4. SHAINBERG, A., G. YAGIL, and D . YAFFE. 1971 .
Enzyme activities during muscle differentia-
tion. Dev. Biol. 25:1 .
5. PATERSON, B., and R. C. STROHMAN. 1972. Myo-
sin synthesis in differentiating cultures of chick
embryo skeletal muscle. Dev. Biol. 29:113.
6. EASTON, T. G., and E. REICH. 1972. Muscle
differentiation in cell culture . J. Biol. Chem.
247(20) :5420.
7. YAFFE, D., and H. DYM. 1972. Gene expression
during the differentiation of contractile muscle
fibers. Cold Spring Harbor Symp. Quant. Biol. 37:
543.
8. LEE, C. Y. 1972. Chemistry and pharmacology of
polypeptide toxins in snake venoms. Annu. Rev.
Pharmacol. 12:265.
9. BARNARD, E . A., J. WIECKOWSKI, and T. H. CHID.
1971 . Cholinergic receptor molecules and
cholinesterase molecules at mouse skeletal mus-
cle junctions. Nature (Lond.). 234:207.
10. BERG, D. K., R. B. KELLY, P. B. SARGENT, P.
WILLIAMSON, and Z . W. HALL. 1972. Binding
of a-bungarotoxin to acetylcholine receptors in
mammalian muscle. Proc Nall. Acad. Sci.
U. S. A. 69:147.
11 . HARTZELL, H. C., and D. M. FAMBROUGH. 1972 .
Acetylcholine receptors: distribution and extra-
junctional density in rat diaphragm after de-
nervation correlated with acetylcholine sensi-
tivity. J. Gen. Physiol. 60:248.
12. CHANGEUX, J. P., M. KASAI, and C . Y. LEE. 1970.
Use of a snake venom toxin to characterize the
cholinergic receptor protein . Proc. Natl. Acad.
Sci. U. S. A. 67:1241.
13. O'NEILL, M., and R. C. STROHMAN. 1969.
Changes in DNA polymerase activity associ-
ated with cell fusion in cultures of embryonic
muscle. J. Cell. Physiol. 73:61.
14. O'NEILL, M ., and F. STOCKDALE. 1972. A kinetic
analysis of myogenesis . J. Cell Biol. 52:52.
15. KARLSSON, E., H. ARNBERG, and D. EAKER.
1971 . Isolation of the principal neurotoxins,
of two Naja naja subspecies . Eur. J. Biochem.
21 :1 .
16. GREENWOOD, F. C., W. M. HUNTER, and J. S.
GLOVES. 1963. The preparation of 1-131-
labeled human growth hormone of high spe-
cific radioactivity . Biochem. J. 89:114.
17. WEBER, M ., A. MENEZ, P. FROMAGEOT, P .
BOQUET, and J. P. CHANGEUX. 1972. Effet des
agents cholinergiques et des anesthesiques
locaux sur la cinetique de liason de la toxine
a tritiee de Naja nigricollis au recepteur
cholinergique. C. R. Acad. Sci. (Paris). 274 :1575.
18. PRIVES, J. M., M. J . REITER, D . A. COWBURN,
and A. KARLIN. 1972. Interactions of cobra
neurotoxin and affinity labels of the acetyl-
choline receptor in the electroplax. Mol.
Pharmacol. 8:786.
19. CLARK, D. G., D. D. MACMURCHIE, E . E.
ELLIOTT, R. G. WOLCOTT, A. M. LANDEL, and
M. A. RAFTERY. 1972. Elapid neurotoxins.
Purification, characterization, and immuno-
chemical studies of a-bungarotoxin . Bio-
chemistry. 11 :1663.
BRIEF NOTES 245